Travere Therapeutics, Inc. (TVTX)
NASDAQ·Healthcare·Biotechnology
$53.87
+1.12%
Mkt Cap $4.55B
Analyst Ratings
Buy
17
Hold
1
Sell
0
Price Target (19 analysts)
$51.50
Range $49.00 – $54.00
Implied Upside
-4.4%
Consensus $51.50 vs current $53.87
NASDAQ·Healthcare·Biotechnology
$53.87
+1.12%
Mkt Cap $4.55B
Buy
17
Hold
1
Sell
0
Price Target (19 analysts)
$51.50
Range $49.00 – $54.00
-4.4%
Consensus $51.50 vs current $53.87